Revenue & Growth

Showing 41-48 of 131 results

Online Dating Industry: The Business of Love

by Melissa Lin

Though matchmaking is one of the oldest industries in existence, online matchmaking is now having a moment of its own. This article explores the business of dating: the market size of dating apps in the U.S., the industry’s biggest players, and how these products actually make money (if they even do).

15 minute readContinue Reading

Navigating the Nuances of Investment Due Diligence

by Stela Ivancheva

Investment due diligence is a necessary process for both buyers and sellers to undertake to ensure the swift execution of their envisaged transaction. Although, with the stakes high, there are certain challenges that can arise throughout the process which, with careful planning and execution, can be mitigated.

14 minute readContinue Reading

The Impending Commercial Robot Revolution

by Francesco Castellano

The field of robotics has seen incredible strides forward in recent years. As a result of improvements in computer vision, dexterity and also overall economics, use of robots has increased in a variety of different fields. However, most of the growth in robotics so far has happened in industrial applications, and thus hidden from the view of the general public. But is this about to change? In this article, Toptal Finance Expert Francesco Castellano focuses on the commercial robotics market. Thanks to recent breakthroughs in the fields of AI, mechatronics, sensors, and batteries, service and commercial robots are likely to see tremendous growth and adoption, likely heralding a new robotics revolution that could transform our daily lives in countless ways.

13 minute readContinue Reading

Should You Go It Alone with a Single-person Startup?

by Alex Graham, CFA

Popular rhetoric states that you need a team to found a startup. But what if you don’t have the desire or the right co-founders to start a new venture in a team? Contrary to popular belief, there are many successful solo ventures. This guide presents some tactics for solo entrepreneurs to follow when starting a solo venture.

14 minute readContinue Reading

Making Your Software Work For You: an ERP Implementation Tutorial

by Ted Bartlett

In the life of almost any growing enterprise, there comes a point in time when the existing systems and processes become insufficient. For most enterprises at this key inflection point, implementing enterprise resource planning (ERP) software, which integrates all areas of the business, can help to overcome this issue. This article provides enterprise leaders with the benefits and risks of ERP, as well as a detailed step-by-step implementation guide.

19 minute readContinue Reading

LTV and CAC: What Are They and Why Do They Matter?

by Ryan Downie

LTV:CAC analysis is one of the most important exercises startup founders must go through to evaluate their business’ prospects and raise external funding. It is, however, frequently misunderstood and misinterpreted. In this article, Toptal Finance Expert Ryan Downie runs through a practical tutorial of how to perform LTV:CAC analysis correctly, and how it should be adapted and interpreted depending on the business model or sector in question.

12 minute readContinue Reading

What’s My Return on Investment and How Do I Calculate It?

by David Bradshaw

Finding out your return on investment from a project can become a subjective process with the myriad of returns measures and formulas that exist. This overview provides a breakdown and explanation of what type of return you need to measure and how to calculate it. With further guidance on how to use returns data to guide objective decision making.

16 minute readContinue Reading

Biotech Valuation Idiosyncrasies and Best Practices

by Raphael Rottgen, CFA FRM

Biotech companies with little to no revenue can still be worth billions. Consider the most prominent 2017 biotech M&A deal when Gilead bought Kite Pharma for almost $12 billion. At the time of the deal, Kite had over $600 million in accumulated deficit, but it also had a pipeline of CAR-T cell therapies, which treat cancer. This article examines how to value such pipelines. It also focuses on the risk-adjusted NPV valuation methodology, portfolios of multiple drug candidates, and how value is impacted by the characteristics of the investor or acquirer.

22 minute readContinue Reading

Join the Toptal® community.